On the healthcare front, there’s much ground to cover as well in the area of pricing and reimbursement of innovative pharmaceuticals. In Canada, this is controlled at three levels: by the federal Patented Medicine Prices Review Board, by the 17 federal, provincial and territorial public drug plans, and by the Common Drug Review. A pharmaceutical manufacturer must obtain the approval of 19 different bodies for the price of a new drug in Canada. This hurdle presents a big challenge to drug manufacturers and some say impedes Canadians’ access to innovative medicines. Continue reading »
During the Partnerships conference, we’d like to invite you join us on 20.11.2013 at 19.30 to Café Frauenhuber, Vienna’s oldest coffee house to savor delicious coffees and treats and enjoy a relaxed conversation with your peers and colleagues. We’d love to share the research we’ve collected this year from your industry peers about their attitudes regarding global clinical trials, and to determine how Lionbridge Life Sciences can help you with your own future multilingual needs. Please let us know if you’d like to join us at Café Frauenhuber by registering here.
We all appear to believe that effective global communication has evolved from a “nice to do” to a “must accomplish” business goal. This is particularly important in the world of science and medicine, as more organizations expand their global footprints into emerging countries, opening up new opportunities to communicate effectively with clinicians, patients, regulating bodies, and of course their extended global employee base.
As with any effort as massive as growing globally and communicating effectively, there are a host of structured educational choices (not to mention a growing list of consultants and service providers). Books, events, and webinars are all available, with varying price points and levels of intensity, typically concluding with considerations on what paths to success look like. Continue reading »
By all accounts, The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 16th Annual European Congress, 2-6 November 2013 at The Dublin Convention Centre, is shaping up to be a must-attend event. There will be numerous topics explored, all of great interest to health care researchers, health technology assessors, manufacturers, governments, and patients, as healthcare decision-making policies and processes are under continual review. Continue reading »
Please join us on Wednesday October 30, 10:30 AM EDT | 14:30 GMT for an informative webcast as we discuss strategies for optimizing your global patient recruitment communications.
The clinical trial landscape is changing, with emerging markets accounting for a growing portion of global spending on pharmaceuticals, and the United States no longer acting as the hub for site locations. Effective patient recruitment and retention play a critical role in meeting the requirements of an efficient global trial approach. Continue reading »
On October 8 and 9, 2013, the 21st edition of the Life Sciences Business Roundtable took place in sunny Santa Clara, California. This initiative of the Localization Institute was moderated and organized by the undersigned in close collaboration with a Life Sciences Advisory Board. Some of the current and past members include representatives from Gambro, Medtronic, Smiths Medical, St. Jude Medical and Siemens Healthcare. Continue reading »
The DIA has long been recognized as playing a significant role in transferring vital information across the globe to raise the level of health and well-being worldwide. Lionbridge Life Sciences had an opportunity to hear from many respected members of DIA about where they stand on key factors surrounding global clinical trials.
Results of our pulse poll, which surveyed more than 100 life sciences leaders at the DIA annual meeting in Boston 2013, revealed that efforts need to continue in helping our life sciences research colleagues adapt to — and comply with — the rapid pace of change. Continue reading »
As electronic records and systems continue to gain acceptance among life sciences leaders and regulators alike, information technology is playing an increasingly important role in the way companies produce their content and ensure its compliance with regulations, including the way documents are revised.
For most of us, editing and saving electronic documents is something we do so often we rarely think about it. We add a few paragraphs to a report, correct some typos and click Save. In regulated industries, however, revisions to documents must be controlled and captured with much greater precision and transparency. Continue reading »
The Digital Marketing for Medical Devices Conference in Minneapolis was a great event, bringing together marketing executives from cutting-edge companies like Medtronic, Zimmer, Olympus America and more, to talk about current digital marketing strategies. The timing was perfect, since the Lionbridge Life Sciences team had recently explored this topic in our white paper and webinar on Managing a Global Online Presence in Medical Device and Diagnostics. I was excited to attend the conference and learn more about how digital marketing strategies are evolving in an increasingly interconnected world. Continue reading »
So much has changed in the past ten years when it comes to developing an online curriculum for an international audience… or has it? I remember early conversations with pharmaceutical training executives whose senior management considered that all their employees around the world had to be proficient in English (“nowadays everybody speaks English”), so why would they need to invest time and money in translations. Working with learning managers to create ROI models and other business cases helped pave the way for the transformation of their organization from “one-size-fits-all English only” to a truly globally integrated and locally empowered business. And later, the opportunity to celebrate their success, when final certification would reach all-time heights and their senior management would recognize the work that had been accomplished around the world. Continue reading »